Point72 Hong Kong’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-79,958
| Closed | -$8.96M | – | 556 |
|
|
2025
Q1 | $8.96M | Sell |
79,958
-40,909
| -34% | -$4.22M | 0.57% | 44 |
|
|
2024
Q4 | $11.2M | Buy |
+120,867
| New | +$10.9M | 0.68% | 35 |
|
|
2024
Q2 | – | Sell |
-9,617
| Closed | -$704K | – | 551 |
|
|
2024
Q1 | $704K | Buy |
+9,617
| New | +$740K | 0.04% | 308 |
|
|
2022
Q4 | – | Sell |
-5,356
| Closed | -$330K | – | 700 |
|
|
2022
Q3 | $330K | Buy |
5,356
+3,328
| +164% | +$210K | 0.01% | 909 |
|
|
2022
Q2 | $125K | Buy |
+2,028
| New | +$126K | ﹤0.01% | 1109 |
|
|
2021
Q4 | – | Sell |
-4,090
| Closed | -$282K | – | 2064 |
|
|
2021
Q3 | $286K | Buy |
+4,090
| New | +$287K | 0.01% | 1080 |
|
|
2021
Q2 | – | Sell |
-27,444
| Closed | -$1.83M | – | 2072 |
|
|
2021
Q1 | $1.77M | Buy |
+27,444
| New | +$1.77M | 0.06% | 437 |
|
|
2020
Q4 | – | Sell |
-23,334
| Closed | -$1.41M | – | 1841 |
|
|
2020
Q3 | $1.47M | Buy |
+23,334
| New | +$1.62M | 0.16% | 151 |
|
|
2019
Q2 | – | Sell |
-2,566
| Closed | -$167K | – | 1216 |
|
|
2019
Q1 | $167K | Buy |
2,566
+1,921
| +298% | +$128K | 0.07% | 223 |
|
|
2018
Q4 | $40K | Buy |
+645
| New | +$45.1K | 0.02% | 341 |
|
|
2018
Q2 | – | Sell |
-1,047
| Closed | -$79K | – | 995 |
|
|
2018
Q1 | $79K | Buy |
1,047
+1,036
| +9,418% | +$82.4K | 0.04% | 370 |
|
|
2017
Q4 | $1K | Sell |
11
-2,970
| -100% | -$226K | ﹤0.01% | 755 |
|
|
2017
Q3 | $242K | Buy |
+2,981
| New | +$228K | 0.17% | 34 |
|
|
2017
Q1 | – | Sell |
-12,602
| Closed | -$902K | – | 815 |
|
|
2016
Q4 | $902K | Buy |
12,602
+4,624
| +58% | +$344K | 0.9% | 13 |
|
|
2016
Q3 | $631K | Buy |
+7,978
| New | +$648K | 0.34% | 75 |
|
|
2016
Q2 | – | Sell |
-300
| Closed | -$28K | – | 567 |
|
|
2016
Q1 | $28K | Sell |
300
-1,178
| -80% | -$106K | 0.05% | 236 |
|
|
2015
Q4 | $150K | Buy |
1,478
+1,400
| +1,795% | +$146K | 0.5% | 57 |
|
|
2015
Q3 | $8K | Sell |
78
-400
| -84% | -$44.4K | 0.01% | 111 |
|
|
2015
Q2 | $56K | Sell |
478
-6,100
| -93% | -$667K | 0.11% | 113 |
|
|
2015
Q1 | $645K | Buy |
6,578
+6,051
| +1,148% | +$614K | 0.57% | 17 |
|
|
2014
Q4 | $50K | Buy |
+527
| New | +$54.5K | 0.05% | 393 |
|
Other funds holding GILD
Point72 Hong Kong's GILD Position: Q2 2025 in Review
Point72 Hong Kong sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 79,958 shares — an estimated $8.96M sold.
Point72 Hong Kong first reported a position in GILD in Q4 2014 and held it in 21 quarters. The position peaked at $11.2M in Q4 2024. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Point72 Hong Kong reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Point72 Hong Kong sold 79,958 Gilead Sciences shares in Q2 2025, an estimated $8.96M.
- Point72 Hong Kong first reported a position in Gilead Sciences in Q4 2014 and held it in 21 quarters.
- Point72 Hong Kong's Gilead Sciences position peaked at $11.2M in Q4 2024.
- 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.